Since 2019, VytlOne has supported the 340B programs of more than 100 health systems and health centers. We’ve published dozens of posts exploring 340B topics and trends — major, minor and developing. Recently, we were asked by a reader to produce a post offering our thoughts on, and predictions for, the program’s future. If there … Read More
Patient Eligibility
The Holistic Pharmacy Approach To 340B Patient Support
How to make Pharmacy “The Easy Part” of the patient experience. Anyone who’s ever been a hospital patient, or patient caregiver, knows that the mental strain of a serious illness can often match the negative impact of the physical trauma. Particularly when an illness is chronic and/or long-term, the stress involved in managing the details … Read More
Optimize Your Health System’s Patient Care & ROI With 340B
Far too many 340B hospitals overlook pharmacy’s overall potential in their health systems’ revenue cycles. Below is a graphic overview of VytlOne’s integrated approach to optimizing a health system’s pharmacy services, savings and revenue. In 340B support alone, we’ve generated over $500 million for the hospitals we serve — revenue those systems have used to … Read More
Empower Your Health System’s 340B Program With Analytics
The automated approach to optimizing 340B savings & patient care while overcoming manufacturer restrictions NOTE: The purpose of this article is to highlight features and functionality any 340B platform needs to optimize a health system’s 340B savings and revenue. That said, we determined that the easiest way to report those features was to describe the … Read More
Is Your 340B Vendor A Partner Or A Parasite?
Why 340B vendors charging Percentage Of Revenue is wrong. The United States Congress established the 340B statute in 1992 to help non-profit hospitals fill-in the often-backbreaking revenue gaps inherent to their business models — enabling covered entities to replenish eligible prescriptions at significant savings. Savings which they can then pass-along to their patients, many of … Read More
Using 340B To Optimize Patient Care And ROI Throughout Your Health System
Below is a graphic overview of VytlOne’s integrated approach to optimizing a health system’s pharmacy services, savings and revenue. In 340B support alone, we’ve generated over $500 million for the hospitals we serve — revenue those systems have used to positively impact the quality and scope of patient care they offer, in countless ways. Why … Read More
Your Hospital’s 340B Contract Pharmacy Network Is Not What It Should Be.
Based on our experience, it’s a claim we can make with 100% certainty. VytlOne has supported the 340B programs of more than 100 health systems and health centers since 2019. Altogether, we’ve generated nearly $1 billion in pharmacy-related savings for our clients. While the average 340B hospital’s revenues have decreased significantly since the 2020 advent … Read More
Is Your 340B Vendor A Partner Or A Parasite?
Why 340B vendors charging Percentage Of Revenue is wrong. From time to time, 340B hospitals are required to purchase non-eligible prescriptions at the Wholesale Acquisition Cost. When that happens, the costs of those medications often exceed reimbursement. Most 340B hospitals already operate on a loss-basis. Which is why, we believe, it’s so wrong for 340B … Read More
Your Hospital’s 340B Contract Pharmacy Network Is Not What It Should Be.
Based on our experience, it’s a claim we can make with 100% certainty. Since 2019, when VytlOne launched its 340B Support Services division, we’ve managed the 340B programs of 18 health systems. We’ve generated more than $500 million in 340B Savings and Revenue. And yet, we’ve never served (or seen) a 340B health system with … Read More
How 340B Programs Can Positively Impact Value-Based Care Scores
It’s no secret that, for hospitals, one of the Affordable Care Act’s most far-reaching legacies is the impact that Value-Based Care has on the payments they receive. For many health systems, the lower their Value-Based Care scores, the lower the payments they receive from treating Medicare and Medicaid patients. What isn’t as commonly considered — … Read More








